(Q36263259)

English

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

phase II clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic squamous cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sandrine Faivre

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sebastian Ochsenreither

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Denis Soulières

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ricard Mesía

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Éva Remenár

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Shau-Hsuan Li

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Andrey Karpenko

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Arunee Dechaphunkul

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Laura Anna Kiss

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jin-Ching Lin

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Raj Nagarkar

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

László Tamás

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sung-Bae Kim

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jozsef Erfán

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Anna Alyasova

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Stefan Kasper

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Carlo Barone

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sabine Turri

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Arunava Chakravartty

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Marie Chol

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Paola Aimone

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Samit Hirawat

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

25 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

323-335

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy for head and neck cancer: latest developments and clinical potential

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of human papillomavirus in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular profiling of head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive genomic characterization of head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic basis for clinical response to CTLA-4 blockade in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930064-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(17)30064-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28131786%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36263259&oldid=1622517914"